A gene known as Myc is linked to cancer growth, but has long been considered “undruggable." Now, researchers at Vanderbilt University have found a way to bypass it and shut down a protein that ...

Potential cancer breakthrough as scientists develop a drug that can block a gene that causes tumors to grow Treatment known scientifically as OMO-103 works by suppressing MYC gene ...

A gene called MYC is implicated in the majority of cancers, but unfortunately it’s often considered “undruggable.” In a new study scientists have developed a molecule that chops up the RNA ...

A gene called Myc (pronounced 'mick') that is among the most important drivers of cancer in both mice and humans also plays a newly discovered crucial role in aging.

“MYC is the most deregulated gene in cancer,” says Charles Lin, a graduate student in the Young lab and co-author of the Cell paper. “It’s been called a bad-boy, a Swiss army knife, and a ...

The drug works by suppressing a protein known as MYC, which is overexpressed in 70 per cent of human cancers. The MYC gene is what tells cells to divide and spread. In healthy cells, it’s a good ...

Now, we have linked the well-known oncogene MYC to this target gene, MTA1, a key regulator of metastasis. Most importantly, if we block MYC's ability to turn on MTA1, we block tumor formation.

New research from a mouse study at UCSF shows that therapies that block action of a gene called Myc may prove useful in fighting cancer. The findings were reported online on August 17, 2008, in Nature ...